Class information for:
Level 1: I 131 MIBG//MIBG//METAIODOBENZYLGUANIDINE

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
12214 859 27.0 70%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
430 15698 PHEOCHROMOCYTOMA//NEUROBLASTOMA//PRIMARY ALDOSTERONISM

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 I 131 MIBG Author keyword 43 66% 5% 40
2 MIBG Author keyword 14 23% 6% 53
3 METAIODOBENZYLGUANIDINE Author keyword 14 28% 5% 42
4 META IODOBENZYLGUANIDINE Author keyword 12 48% 2% 19
5 I 131 METAIODOBENZYLGUANIDINE Author keyword 11 57% 2% 13
6 I 131MIBG Author keyword 10 73% 1% 8
7 3 IODOBENZYLGUANIDINE Author keyword 9 48% 2% 13
8 MIBG SCAN Author keyword 8 70% 1% 7
9 I 131 MIBG THERAPY Author keyword 7 64% 1% 7
10 TARGETED THER Y GRP Address 4 47% 1% 7

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 I 131 MIBG 43 66% 5% 40 Search I+131+MIBG Search I+131+MIBG
2 MIBG 14 23% 6% 53 Search MIBG Search MIBG
3 METAIODOBENZYLGUANIDINE 14 28% 5% 42 Search METAIODOBENZYLGUANIDINE Search METAIODOBENZYLGUANIDINE
4 META IODOBENZYLGUANIDINE 12 48% 2% 19 Search META+IODOBENZYLGUANIDINE Search META+IODOBENZYLGUANIDINE
5 I 131 METAIODOBENZYLGUANIDINE 11 57% 2% 13 Search I+131+METAIODOBENZYLGUANIDINE Search I+131+METAIODOBENZYLGUANIDINE
6 I 131MIBG 10 73% 1% 8 Search I+131MIBG Search I+131MIBG
7 3 IODOBENZYLGUANIDINE 9 48% 2% 13 Search 3+IODOBENZYLGUANIDINE Search 3+IODOBENZYLGUANIDINE
8 MIBG SCAN 8 70% 1% 7 Search MIBG+SCAN Search MIBG+SCAN
9 I 131 MIBG THERAPY 7 64% 1% 7 Search I+131+MIBG+THERAPY Search I+131+MIBG+THERAPY
10 131 I METAIODOBENZYLGUANIDINE 4 75% 0% 3 Search 131+I+METAIODOBENZYLGUANIDINE Search 131+I+METAIODOBENZYLGUANIDINE

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 I 131 METAIODOBENZYLGUANIDINE 119 54% 18% 152
2 RADIOIODINATED METAIODOBENZYLGUANIDINE 39 80% 3% 24
3 MIBG 38 40% 9% 74
4 METAIODOBENZYLGUANIDINE 36 24% 15% 130
5 RADIOLABELED METAIODOBENZYLGUANIDINE 27 83% 2% 15
6 M IODOBENZYLGUANIDINE 26 63% 3% 26
7 REFRACTORY NEUROBLASTOMA 25 46% 5% 41
8 IODINE 131 METAIODOBENZYLGUANIDINE THERAPY 24 91% 1% 10
9 NEURAL CREST TUMORS 23 43% 5% 41
10 SK N SH 22 40% 5% 44

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Nothing but NET: A Review of Norepinephrine Transporter Expression and Efficacy of I-131-mIBG Therapy 2015 1 87 72%
A systematic review of (131) I-meta iodobenzylguanidine molecular radiotherapy for neuroblastoma 2014 4 39 79%
Nuclear medicine and multimodality imaging of pediatric neuroblastoma 2013 11 73 60%
Functional-metabolic imaging of neuroblastoma 2013 7 88 65%
Pediatrics: Diagnosis of Neuroblastoma 2011 21 70 67%
Neuroblastoma and other neuroendocrine tumors 2007 53 116 52%
Radiolabeled metaiodobenzylguanidine for the treatment of neuroblastoma 2008 28 92 86%
Radioiodinated Metaiodobenzylguanidine (MIBG): Radiochemistry, Biology, and Pharmacology 2011 15 46 67%
Radiolabeled metaiodobenzylguanidine for imaging and therapy of neuroblastoma 2008 29 91 71%
I-123-Meta-Iodobenzylguanidine Scintigraphy for the Detection of Neuroblastoma and Pheochromocytoma: Results of a Meta-Analysis 2010 48 48 44%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 TARGETED THER Y GRP 4 47% 0.8% 7
2 W GLASGOW HOSP UNIV TRUST 3 100% 0.3% 3
3 CANC UNITED KINGDOM BEATSON S 2 67% 0.2% 2
4 GLASGOW CANC STUDIES 1 100% 0.2% 2
5 SEMONOV 1 100% 0.2% 2
6 JOINT PROGRAM NUCL MED 1 21% 0.3% 3
7 CHILDRENS ONCOL GRP COG 1 50% 0.1% 1
8 DIPARTIMENTO MED SPERIMENTALE ANAT PATOL 1 50% 0.1% 1
9 SURG LEVEL 2 1 50% 0.1% 1
10 PEDIAT NUCL MED 1 22% 0.2% 2

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000219296 IODINE 123 METAIODOBENZYLGUANIDINE//METAIODOBENZYLGUANIDINE//I 123 MIBG
2 0.0000158280 PHEOCHROMOCYTOMA//PARAGANGLIOMA//PHAEOCHROMOCYTOMA
3 0.0000143523 NEUROBLASTOMA//MYCN//MYCN AMPLIFICATION
4 0.0000101878 SOMATOSTATIN RECEPTOR SCINTIGRAPHY//PEPTIDE RECEPTOR RADIONUCLIDE THERAPY//OCTREOTATE
5 0.0000085860 GANGLIONEUROMA//COMPOSITE PHEOCHROMOCYTOMA//CUTANEOUS GANGLIONEUROMA
6 0.0000083509 EPIDURAL COMPRESSION//BONE SOFT TISSUE TUMORS UNIT//MANDIBLE LESION
7 0.0000056384 PRIMARY ADRENAL LYMPHOMA//ADRENAL INCIDENTALOMA//ADRENAL GLAND NEOPLASMS
8 0.0000044796 IMMUNOCYTOKINES//IMMUNOCYTOKINE//PHILOCHEM AG
9 0.0000040803 RADIOIMMUNOTHERAPY//PRETARGETING//Y 90 IBRITUMOMAB TIUXETAN
10 0.0000040337 EGF DEXTRAN//ANTIBODY BINDING PARAMETERS//BIOMED RADIAT SCI